Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccination

QJM. 2021 Dec 20;114(10):745-746. doi: 10.1093/qjmed/hcab245.

Authors

K Ishizuka¹, K Katayama¹, Y Kaji¹, J Tawara¹, Y Ohira¹

Affiliation

¹ Department of General Medicine, International University of Health and Welfare Narita Hospital, 852 Hatakeda, Narita-city, Chiba pref., Japan.

No abstract available

MeSH terms

Angioedema* / chemically induced
BNT162 Vaccine
COVID-19 Vaccines
COVID-19*
Eosinophilia*
Humans
RNA, Messenger
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines
RNA, Messenger
BNT162 Vaccine